The UKs research nurses are on the front line of trials at an unprecedented scale and pace
More than 100,000 people with COVID-19 have been treated in hospital during the pandemic.
Clinical staff, including nurses, have played a crucial role in caring for and supporting them.
But alongside these staff is an army of research nurses whose role, while less visible, has been just as important.
UK-based vaccine trials have been set up
The network of 5,000 research nurses in the NHS has been helping the health service trial new treatments, develop vaccines and understand more about the new disease.
Association of UK Lead Research Nurses (AUKLRN) chair Heather Iles-Smith says it has been incredibly busy, with trials set up at record pace.
Almost overnight, existing research programmes were paused at the start of the pandemic apart from those where this would have detrimental effects for ongoing patient care.
In total, nearly 50 different COVID-19 treatment trials have been prioritised by the National Institute for Health Research (NIHR) for NHS trusts to focus on some involving multiple treatments.
Meanwhile, human trials have begunin two UK-based vaccine programmes one run by Oxford University and one by Imperial College London. The Oxford vaccine trial now involves 18 different NHS trusts.
On top of this there is work being done on antibody testing, genetics research and observational studies.
The National Institute of Health Research (NIHR) has identified a number of priority trials that NHS trusts have been asked to take part in. These have been looking at whether a range of existing treatments, from blood thinning drugs to anti-inflammatory treatments and antiviral medication, can help. The largest is the RECOVERY trial, but other major studies include REMAP-CAP, which is focused on intensive care patients, and ACCORD. Strong evidence has been found for the effectiveness of the steroid dexamethasone in treating patients with COVID-19. Research from the RECOVERY trial published in June showed the steroid cut the risk of death by a third for patients on ventilators and a fifth for those given oxygen. It is now being used as a front-line treatment.
Two UK-based vaccine trials have been set up. The first one to get under way is run by Oxford University. Human trials started in April, with 1,000 participants recruited by May. The next phase will see another 10,000 recruited across 18 sites. Human trials for the second vaccine, developed by Imperial College London, which started in lateJune. There are about 150 other vaccine trials around the world in various stages of development.
Research nurses have been seconded to work on the governments antibody test programmes. REACT-2 has been looking at the effectiveness of self-administered tests. Members of the public and front-line health workers have been recruited. The second programme is called SIREN and focuses on the antibody test developed by Roche that is being offered to healthcare staff across the country. The aim is to recruit 10,000 healthcare workers and regularly monitor those that have antibodies over the course of the year to see if they become infected.
Research nurses working with clinical research practitioners have taken samples and recorded data as part of observational studies. One of the largest is the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) scheme, a global network, which has tracked the spread and behaviour of COVID-19 since it first emerged. Hospitals in England, Scotland and Wales have taken part.
NHS Blood and Transplant is coordinating a programme that will look at whether blood plasma transfusions could help people with COVID-19. The theory is that antibodies in the plasma of people who have been infected could help patients who are struggling with the disease. Blood is being collected and transfusions have started at a number of sites.
A Genomics England and Edinburgh University-led study is collecting DNA from intensive care patients as well as those with only mild to moderate illness to see what role a persons genes play in the chances of them getting seriously ill with the infection. More than 160 hospitals are involved.
Dr Iles-Smith, who is also head of nursing research and innovation at Leeds Teaching Hospitals NHS Trust, says these efforts represent research at an unprecedented scale and pace.
Research nurses have had to set up and recruit patients within a matter of weeks, whereas it normally takes months to get a trial off the ground and recruit the first patient.
But she says it has meant there have been some real challenges that have had to be faced, from staffing redeployments to coping with the tight isolation and infection control measures introduced on wards and in intensive care.
In some trusts, we have had to up-skill research nurses to deliver drugs intravenously many are only used to giving drugs orally. In other areas they have engaged clinical nurses to give the drugs and take samples and hand them to research staff.
But that is not without difficulties. Patients have been in isolation areas so staff have taken the samples to the door and dropped them in a bag that is then sealed.
Phones and tablets have been used to scan consent forms because they have not been able to be taken out of the isolation areas.
Dr Iles-Smith says the way clinical and research teams worked collaboratively has been really impressive.
It has brought them together in a way that has not always happened. I've been on wards and in critical care and staff have been really interested in what we are doing.
Nowhere has that been clearer than at the University Hospitals of Leicester NHS Trust.
lab-confirmed cases of COVID-19 were recorded in the UK as of 23 June 2020
Source: Gov.uk
More than 600 patients thought to be the highest from a single trust were recruited to the multi-drug RECOVERY trial, the UKs biggest treatment trial and the source of the recent breakthrough with the steroid drug dexamethasone.
Key to the success, says the trusts nursing and midwifery head of research Antonella Ghezzi, is the fact research nurses and clinical staff worked side by side across the trusts three sites, even in intensive care.
Weve had a close working relationship with clinical staff. I think COVID-19 has meant we have had a clear, shared goal, says Ms Ghezzi.
Clinical staff were trying to treat patients who were really struggling because of this new disease. They understood we needed to try things and find a way of treating these patients.
My research nurses were on the wards, working alongside the clinical staff.
The consultants would identify which patients to put in which arms of the trials. They would talk to families, but the patients were so acutely ill they could not give consent. When they recovered a little and were awake we would have to get consent from them.
Clinical and research staff have also come together in a different way to work on vaccine trials.
Phase one of the Oxford University trial saw more than 1,000 participants recruited and they will be followed by another 10,000 in phase two.
Clinical staff, including those working in intensive care units, emergency departments, hospital wards and in the community and care homes, are among those coming forward to be participants.
Vaccine programme leader Sarah Gilbert says staff, including nurses, are being asked to play a crucial role because rates of infection have fallen so low in the UK.
Unless some of the trial participants become infected we cannot know that the vaccine is effective, Professor Gilbert says.
So we are focusing on vaccinating healthcare workers as they have the highest rates of infection.
Research nurses have been working 24/7 nights and weekends alongside clinical staff. Working at this pace, setting up trials in a matter of weeks is not normal. But the team has responded amazingly
Helen Jones, head of research nursing, Royal Free NHS Trust
Alongside this, nurses and other staff are coming forward for antibody tests and then being monitored to see how long any immunity lasts, while staff who have been infected are also donating blood plasma under the NHS Blood and Transplant programme to see if transfusions can help people who are infected fight off the virus.
But, as with clinical staff treating patients, the impact of being on the front line of the pandemic is taking its toll on research staff.
The AUKLRN has been running fortnightly telephone calls for members to provide peer support as well as share best practice.
Ms Ghezzi says the last few months have been very hard for staff. Some of her 90-strong team who had relevant experience were redeployed to clinical work in intensive care.
For those nurses who have gone back, there has been an obvious mental strain. But a lot of our nurses have been working in intensive care for the research work and they are affected too.
Royal Free NHS Trust head of research nursing Helen Jones says she has also had to juggle with redeployment.
people have been recruited to the Oxford human vaccines trial
As soon as it became clear COVID-19 was spreading, I looked at the team to see who had the necessary experience. Eight went to work in intensive care and spent nearly two months there.
The team has worked incredibly hard. You have to remember there was no set treatment for COVID-19 so patients have had to participate in trials to access treatment.
Research nurses have been working 24/7 nights and weekends alongside clinical staff.
Working at this pace, setting up trials in a matter of weeks is not normal. But the team has responded amazingly, working above their contracted hours to do the best for patients.
Susanne Fagerbrink is at the centre of vaccine research in the UK.
Imperial College Healthcare NHS Trust was one of four sites involved in the first phase of the Oxford University trial and has now started developing its own vaccine.
Ms Fagerbrink has played a key role as lead nurse for the trusts National Institute for Health Research clinical research facility.
She says: We have had to completely transform the way we run trials in terms of getting participants in and out. We are adhering to social distancing and have reconfigured our spaces with separate entrances and exits.
We are seeing many more people about 60 a day when it used to be 20 or so before this. The pace and scale of the research is unprecedented.
A lot of our other work has had to take a back seat. We hope in the future we will be able to get back to it but all the attention is understandably on COVID-19. Ive never known anything like it.
More than 40 health staff came forward to be participants in phase one, with 37 going on to be vaccinated.
The response has been very good. It is difficult for health staff they are in hospital all day and then we are asking them to come back to take part in the study.
Participants had to stay an hour for observation and then kept diaries that recorded their daily temperature. If they develop symptoms, they have to return and do a swab test, although this has not happened.
There is a follow-up visit at 28 days then two or three more until day 365.
But staff understand why it is important and they want to help.
Nick Evans is a health journalist
Original post:
COVID-19: how nurses are taking the lead in the quest to find a vaccine and treatment - RCNi
- Rally for Multiple Sclerosis Treatment Funding - May 7th, 2011 [May 7th, 2011]
- Breakthrough Multiple Sclerosis Treatment? - May 8th, 2011 [May 8th, 2011]
- Multiple Sclerosis Treatment - Mayo Clinic - May 11th, 2011 [May 11th, 2011]
- Tracy Macchia: Controversial MS Treatment - May 14th, 2011 [May 14th, 2011]
- What is Multiple Sclerosis - May 19th, 2011 [May 19th, 2011]
- MS Multiple Sclerosis treatment testimonial from Sanoviv Medical Institute - May 20th, 2011 [May 20th, 2011]
- Patient with progressive ms(paraplegia) Fmr treatment 1/4 - May 22nd, 2011 [May 22nd, 2011]
- New Jersey Multiple Sclerosis Treatment with Chiropractic Care - May 23rd, 2011 [May 23rd, 2011]
- MS Cure - Progression - June 2nd, 2011 [June 2nd, 2011]
- CCSVI UK Multiple Sclerosis Liberation Treatment - June 2nd, 2011 [June 2nd, 2011]
- Stem Cell Therapy MS: Sam Harrell and The Superbowl - June 3rd, 2011 [June 3rd, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach Dallas, TX 2011 - June 8th, 2011 [June 8th, 2011]
- MS treatment sees early success - June 9th, 2011 [June 9th, 2011]
- CCSVI Possible cure for Multiple sclerosis - June 10th, 2011 [June 10th, 2011]
- MS Cure - Introduction to stem cell bone marrow transplant in Australia - June 11th, 2011 [June 11th, 2011]
- (Multiple Sclerosis Cure) Change Your Thinking? (Multiple Sclerosis Cure) - June 12th, 2011 [June 12th, 2011]
- Essiac cancer treatment herbal tincture, Ms Caisse...from The Secrets of Eden - June 12th, 2011 [June 12th, 2011]
- MS walking treatment breakthrough - June 14th, 2011 [June 14th, 2011]
- multiple sclerosis natural treatment | Kathy Canada Testimonial - June 18th, 2011 [June 18th, 2011]
- CCSVI Surgery India - Liberation Procedure Multiple Sclerosis Treatment in India - June 29th, 2011 [June 29th, 2011]
- XCell-Center MS CCSVI Liberation Angioplasty Treatment Results E.Schuurman 18_01_11 - July 1st, 2011 [July 1st, 2011]
- MS Cure - 7PM Project Carmel Turner MS Stem Cell Treatment - July 9th, 2011 [July 9th, 2011]
- MS Update! Tysabri or Gilenya? - July 10th, 2011 [July 10th, 2011]
- What causes BSE, CJD - July 15th, 2011 [July 15th, 2011]
- Kath Bartlett, MS, LAc Balance Method Acupuncture - July 16th, 2011 [July 16th, 2011]
- MS Cure - 730 report ben leahy carmel turner ms stem cell treatment - July 17th, 2011 [July 17th, 2011]
- CCSVI LIberation Treatment Tokuda - July 18th, 2011 [July 18th, 2011]
- FOX News Interview on the O'Reilly Factor - Treatment of Women in Islam - July 18th, 2011 [July 18th, 2011]
- CCSVI treatment bloopers holy crap - July 18th, 2011 [July 18th, 2011]
- Tarah's CCSVI Venoplasty. Dr McGuckin Explaining procedure findings - July 19th, 2011 [July 19th, 2011]
- Cancer Cure: The One-Minute Cure For Cancer, MS - July 24th, 2011 [July 24th, 2011]
- Not Ready to Cheer CCSVI Trials - July 29th, 2011 [July 29th, 2011]
- New Oral Treatment for MS - July 30th, 2011 [July 30th, 2011]
- 27/07/2011 - MS patients seek controversial treatment - August 1st, 2011 [August 1st, 2011]
- MS Cure - 11 I am still walking - August 5th, 2011 [August 5th, 2011]
- Upcoming Treatments for MS - Pt 1 -MSRA Public Lecture - Dr Suzanne Hodgkinson - August 10th, 2011 [August 10th, 2011]
- Stem Cells for MS Community Outreach: Patient Judi Lecoq - Dallas, TX 2011 - August 18th, 2011 [August 18th, 2011]
- Stem Cell Treatment for Multiple Sclerosis - Community Outreach, San Diego: David Oliver - August 19th, 2011 [August 19th, 2011]
- New Study Tests Possible Treatment for MS - August 25th, 2011 [August 25th, 2011]
- Professor Dimitrios Karussis: Treating MS - August 26th, 2011 [August 26th, 2011]
- walking with MS before CCSVI treatment.wmv - August 27th, 2011 [August 27th, 2011]
- Suzy Cohen Discusses The Liberation Treatment for MS - September 14th, 2011 [September 14th, 2011]
- Multiple Sclerosis MS People - Amazing New Treatment - September 15th, 2011 [September 15th, 2011]
- Multiple Sclerosis Alternative Treatment - September 17th, 2011 [September 17th, 2011]
- CLEAR scoliosis treatment, Dr. Culpepper (MS) - September 22nd, 2011 [September 22nd, 2011]
- Liberation treatment for MS - September 23rd, 2011 [September 23rd, 2011]
- 44b - My Lyme disease and rheumatoid arthritis journey - Miraculous CCSVI treatment for MS sufferers - September 24th, 2011 [September 24th, 2011]
- A Closer Look at Gilenya - The First Oral Treatment for MS - September 28th, 2011 [September 28th, 2011]
- Unequal Treatment Drives Disability Rights Movement - September 28th, 2011 [September 28th, 2011]
- Multiple Sclerosis - The Nebraska Medical Center - September 29th, 2011 [September 29th, 2011]
- Testimonial for CCSVI Treatment Excel Heart Center Mexico -- Tanya Reay - September 30th, 2011 [September 30th, 2011]
- Current thinking on what causes MS - Pt 1 - MSRA Public Lecture -Prof Graeme Stewart - October 2nd, 2011 [October 2nd, 2011]
- Current and emerging therapies in MS - Part 02 (How do these treatments work?) - October 2nd, 2011 [October 2nd, 2011]
- MS Richard Humphries before and after treatment for Multiple Sclerosis with stem cells - October 3rd, 2011 [October 3rd, 2011]
- Matthew - CCSVI and his Liberation Treatment - October 8th, 2011 [October 8th, 2011]
- Multiple Sclerosis - Myelin Repair - Video - October 14th, 2011 [October 14th, 2011]
- MS Auto Immune vs CCSVI Treatment Simple Pictures by Berukoff - Video - October 23rd, 2011 [October 23rd, 2011]
- New Promising Treatment for Those Living with Multiple Sclerosis - Video - October 29th, 2011 [October 29th, 2011]
- Stem cells to treat MS - Pt 2 - MSRA Public Lecture - A/Prof Richard Burt - Video - October 30th, 2011 [October 30th, 2011]
- New hope for treating multiple sclerosis - Video - October 31st, 2011 [October 31st, 2011]
- CCSVI Multiple sclerosis Breakthrough/cure - Video - October 31st, 2011 [October 31st, 2011]
- Inhuman Treatment of Wheelchair bound Multiple Sclerosis Patient in Canadian Care Home - Video - November 9th, 2011 [November 9th, 2011]
- MS treatment movie Cells4health.mp4 - Video - November 10th, 2011 [November 10th, 2011]
- Racing to the Cure for MS: Myelin Repair Foundation Celebrates MS Awareness Week - Video - November 12th, 2011 [November 12th, 2011]
- [Symptoms of Multiple Sclerosis] - Video - November 12th, 2011 [November 12th, 2011]
- Multiple Sclerosis Treated with Adult Stem Cells - Video - November 13th, 2011 [November 13th, 2011]
- Stem cells to treat MS - Pt 1 - MSRA Public Lecture - A/Prof Richard Burt - Video - November 16th, 2011 [November 16th, 2011]
- Multiple Sclerosis A Natural Treatment - Video - November 16th, 2011 [November 16th, 2011]
- My MS and Stem Cell Treatment - Video - November 16th, 2011 [November 16th, 2011]
- CCSVI Liberation News Reports - Video - November 20th, 2011 [November 20th, 2011]
- Stem Cells for MS Community Outreach: Patient Sam Harrell - Dallas, TX 2011 - Video - November 21st, 2011 [November 21st, 2011]
- Arthur S13 E2-1 - The Silent Treatment - Video - November 27th, 2011 [November 27th, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach San Diego CA - Video - December 3rd, 2011 [December 3rd, 2011]
- CCSVI - Video - December 3rd, 2011 [December 3rd, 2011]
- My Sister's Experience with Liberation Treatment for Multiple Sclerosis PART 2/2 - Video - December 5th, 2011 [December 5th, 2011]
- Multiple Sclerosis -- Treatment LDN story - Video - December 7th, 2011 [December 7th, 2011]
- ABC News - Multiple Sclerosis effectively treated by a new acoustic medical device. - Video - December 9th, 2011 [December 9th, 2011]
- MS Patient After Stem Cell Therapy - Video - December 10th, 2011 [December 10th, 2011]
- Multiple Sclerosis - Video - December 12th, 2011 [December 12th, 2011]
- Journey of Connective Tissue, Autoimmune disease, steroid treatment updates. - Video - December 22nd, 2011 [December 22nd, 2011]